SAN DIEGO, May 29, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025. UroGen engages in the development and...
Read More Details
Finally We wish PressBee provided you with enough information of ( URGN Stockholder Alert: Robbins LLP Informs Investors of the UroGen Pharma Ltd. Class Action Lawsuit )
Also on site :
- Trump’s Gulf deals and political promises
- Israel Orders Evacuation of Much of Northern Gaza, Warning of Dangerous Combat
- The ruinous consequences for Israel and Gaza of Netanyahu’s endless war